IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by IRADIMED CORPORATION on January 18, 2017. The report serves as a current disclosure regarding the Company's financial guidance and updated revenue estimates.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it references a press release (Exhibit 99.1) containing:
- Updated revenue estimates for the full year 2016 and the fourth quarter of 2016.
- Financial guidance for the full year 2017 and the first quarter of 2017.
Material Changes
The Company announced updated revenue estimates for the fourth quarter and full year 2016. The filing does not detail the specific magnitude of changes versus prior periods or prior guidance within the text provided.
Guidance, Outlook, and Risks
Management issued updated financial guidance for 2017 and Q1 2017. The filing includes a standard Regulation FD disclosure stating that the information in Items 2.02 and 7.01 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act. No specific risks or contingencies are detailed in the body of this report.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 18, 2017) for specific revenue figures and guidance numbers.
- Verify the specific adjustments made to the 2016 fourth quarter and full-year revenue estimates.
- Confirm the details of the 2017 full-year and Q1 financial guidance provided in the press release.